---
title: "12 Health Care Stocks Moving In Monday's Intraday Session"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/296132792.md"
description: "During Monday's intraday session, several healthcare stocks experienced significant volatility. INVO Fertility surged 108.9% to $2.03, while OSR Health rose 83.98%. Other gainers included Acurx Pharmaceuticals, Axe Compute, Nanobiotix, and argenx. Conversely, EyePoint plummeted 69.0%, with NexGel, Citius Pharmaceuticals, BioXcel Therapeutics, OneMedNet, and Akanda also posting notable declines."
datetime: "2026-08-17T17:06:16.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/296132792.md)
  - [en](https://longbridge.com/en/news/296132792.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/296132792.md)
generator: "portal-rs"
---

# 12 Health Care Stocks Moving In Monday's Intraday Session

### Gainers

-   **INVO Fertility** (NASDAQ:IVF) shares moved upwards by 108.9% to $2.03 during Monday's regular session. The market value of their outstanding shares is at $1.7 million. As per the press release, Q2 earnings came out today.
-   **OSR Health** (NASDAQ:OSRH) stock rose 83.98% to $0.58. The company's market cap stands at $11.0 million.
-   **Acurx Pharmaceuticals** (NASDAQ:ACXP) shares rose 20.07% to $1.68. The company's market cap stands at $5.9 million. As per the press release, Q2 earnings came out yesterday.
-   **Axe Compute** (NASDAQ:AGPU) stock moved upwards by 18.63% to $9.81. The company's market cap stands at $94.1 million. The company's, Q2 earnings came out yesterday.
-   **Nanobiotix** (NASDAQ:NBTX) stock increased by 17.93% to $45.18. The company's market cap stands at $1.9 billion.
-   **argenx** (NASDAQ:ARGX) shares moved upwards by 15.99% to $987.46. The company's market cap stands at $53.2 billion.

### Losers

-   **EyePoint** (NASDAQ:EYPT) stock declined by 69.0% to $4.58 during Monday's regular session. The market value of their outstanding shares is at $1.2 billion.
-   **NexGel** (NASDAQ:NXGL) shares fell 28.29% to $0.41. The market value of their outstanding shares is at $5.2 million. The company's, Q2 earnings came out today.
-   **Citius Pharmaceuticals** (NASDAQ:CTXR) shares declined by 25.4% to $0.56. The market value of their outstanding shares is at $20.7 million. As per the press release, Q3 earnings came out yesterday.
-   **BioXcel Therapeutics** (NASDAQ:BTAI) stock decreased by 24.98% to $0.89. The market value of their outstanding shares is at $36.7 million. The company's, Q2 earnings came out 2 days ago.
-   **OneMedNet** (NASDAQ:ONMD) stock fell 21.38% to $0.61. The market value of their outstanding shares is at $44.4 million.
-   **Akanda** (NASDAQ:AKAN) stock fell 20.78% to $5.11. The market value of their outstanding shares is at $3.4 million. **See Also:** www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

### Related Stocks

- [NBTX.US](https://longbridge.com/en/quote/NBTX.US.md)
- [OSRHW.US](https://longbridge.com/en/quote/OSRHW.US.md)
- [BTAI.US](https://longbridge.com/en/quote/BTAI.US.md)
- [EYPT.US](https://longbridge.com/en/quote/EYPT.US.md)
- [NXGL.US](https://longbridge.com/en/quote/NXGL.US.md)
- [AKAN.US](https://longbridge.com/en/quote/AKAN.US.md)
- [CTXR.US](https://longbridge.com/en/quote/CTXR.US.md)
- [ONMD.US](https://longbridge.com/en/quote/ONMD.US.md)
- [IVF.US](https://longbridge.com/en/quote/IVF.US.md)
- [ARGX.US](https://longbridge.com/en/quote/ARGX.US.md)
- [OSRH.US](https://longbridge.com/en/quote/OSRH.US.md)
- [ACXP.US](https://longbridge.com/en/quote/ACXP.US.md)
- [AGPU.US](https://longbridge.com/en/quote/AGPU.US.md)
- [NXGLW.US](https://longbridge.com/en/quote/NXGLW.US.md)
- [ONMDW.US](https://longbridge.com/en/quote/ONMDW.US.md)

## Related News & Research

- [argenx (ENXTBR:ARGX) Hits A Phase 3 Win, Is The Upside Fully Priced?](https://longbridge.com/en/news/296529685.md)
- [RBC Capital Keeps Their Buy Rating on arGEN X (0QW0)](https://longbridge.com/en/news/296296197.md)
- [EYPT: DURAVYU reduced treatment burden by 42% and maintained strong safety in wet AMD](https://longbridge.com/en/news/296109785.md)
- [Goldman Sachs Remains a Buy on arGEN X (0QW0)](https://longbridge.com/en/news/296183571.md)
- [EyePoint's eye drug misses main goal in late-stage trial](https://longbridge.com/en/news/296096290.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**